BBVA USA’s Eli Lilly LLY Stock Holding History

BBVA USA’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$983K	Buy	4,256 +16	+0.4%	+$3.95K	0.06%	267
2021 Q2	$973K	Buy	+4,240	New	+$852K	0.05%	274

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BBVA USA's LLY Position: Q3 2021 in Review

BBVA USA increased its Eli Lilly (LLY) stake by 0.38% in Q3 2021, buying an estimated $3.95K and bringing the position to 4,256 shares worth $983K. The position accounts for 0.06% of the portfolio, ranked #267.

BBVA USA first reported a position in LLY in Q2 2021 and has held it in 2 quarters since. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

BBVA USA held 4,256 shares of Eli Lilly worth $983K as of Q3 2021.
BBVA USA bought 16 Eli Lilly shares in Q3 2021, an estimated $3.95K.
Eli Lilly made up 0.06% of BBVA USA's portfolio in Q3 2021, its #267 holding.
BBVA USA first reported a position in Eli Lilly in Q2 2021 and has held it in 2 quarters since.
2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.